TY  - JOUR
AU  - Gonzalez-Gil, Ines
AU  - Zian, Debora
AU  - Vazquez-Villa, Henar
AU  - Hernandez-Torres, Gloria
AU  - Martinez, R Fernando
AU  - Khiar-Fernandez, Nora
AU  - Rivera, Richard
AU  - Kihara, Yasuyuki
AU  - Devesa, Isabel
AU  - Mathivanan, Sakthikumar
AU  - Del Valle, Cristina Rosell
AU  - Zambrana-Infantes, Emma
AU  - Puigdomenech, Maria
AU  - Cincilla, Giovanni
AU  - Sanchez-Martinez, Melchor
AU  - Rodriguez de Fonseca, Fernando
AU  - Ferrer-Montiel, Antonio V
AU  - Chun, Jerold
AU  - Lopez-Vales, Ruben
AU  - Lopez-Rodriguez, Maria L
AU  - Ortega-Gutierrez, Silvia
PY  - 2019
DO  - 10.1021/acs.jmedchem.9b01287
UR  - http://hdl.handle.net/10668/14777
T2  - Journal of medicinal chemistry
AB  - Neuropathic pain (NP) is a complex chronic pain state with a prevalence of almost 10% in the general population. Pharmacological options for NP are limited and weakly effective, so there is a need to develop more efficacious NP attenuating drugs....
LA  - en
PB  - American Chemical Society
KW  - Analgesics
KW  - Animals
KW  - Cell line
KW  - Cell movement
KW  - Cells, cultured
KW  - Analgesics
KW  - Animals
KW  - Cell Line
KW  - Cell movement
KW  - Cells, cultured
KW  - Drug discovery
KW  - Female
KW  - Humans
KW  - Hydrocarbons, aromatic
KW  - Mice, inbred C57BL
KW  - Models, molecular
KW  - Neuralgia
KW  - Pain perception
KW  - Rats, wistar
KW  - Receptors, lysophosphatidic acid
KW  - Sensory receptor cells
TI  - A Novel Agonist of the Type 1 Lysophosphatidic Acid Receptor (LPA1), UCM-05194, Shows Efficacy in Neuropathic Pain Amelioration.
TY  - research article
VL  - 63
ER  -